Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
| Image |  |
|---|---|
| Description | scientific article published on 6 June 2016 |
| Author/s |
author: Sarah Woodring Annick Desjardins John P. Kirkpatrick Katherine B Peters Mary Lou Affronti Henry Seth Friedman Frances McSherry James H. Herndon James J Vredenburgh |
| Publication date | June 6, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |